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MicroRNAs (miRNAs) regulate key biological pro-
cesses and their aberrant expression may lead to
cancer. The primary transcript of canonical miRNAs
is sequentially cleaved by the RNase III enzymes,
Drosha and Dicer, which generate 50 monophos-
phate ends that are important for subsequent miRNA
functions. In particular, the recognition of the 50
monophosphate of pre-miRNAs by Dicer is im-
portant for precise and effective biogenesis of
miRNAs. Here, we identify a RNA-methyltransferase,
BCDIN3D, that O-methylates this 50 monophosphate
and negatively regulates miRNA maturation. Specifi-
cally, we show that BCDIN3D phospho-dimethylates
pre-miR-145 both in vitro and in vivo and that phos-
pho-dimethylated pre-miR-145 displays reduced
processing by Dicer in vitro. Consistently, BCDIN3D
depletion leads to lower pre-miR-145 and concomi-
tantly increased mature miR-145 levels in breast
cancer cells, which suppresses their tumorigenic
phenotypes. Together, our results uncover a miRNA
methylation pathway potentially involved in cancer
that antagonizes the Dicer-dependent processing
of miR-145 as well as other miRNAs.INTRODUCTION
MicroRNAs (miRNAs) are short single-stranded RNA molecules
(18–24 nucleotides) that posttranscriptionally interfere with
gene expression in a variety of eukaryotes (Ghildiyal and Za-
more, 2009). miRNAs target the RNA interference effector com-
plex (RISC) to specificmessenger RNAs (mRNAs) through partial
base-paring to sequences predominantly found in the 30 un-
translated region (30UTR). This interaction results in decreased
translation of the proteins they encode and/or in the degradation
of the mRNAs themselves (Fabian et al., 2010). To date, over
1,000 human miRNAs have been identified, and each of them
potentially regulates many mRNAs (Friedman et al., 2009; Kozo-
mara and Griffiths-Jones, 2011). Consequently, miRNAs have278 Cell 151, 278–288, October 12, 2012 ª2012 Elsevier Inc.been involved in numerous cellular processes, including devel-
opment, differentiation, proliferation, apoptosis, the stress re-
sponse, and viral defense (Fabian et al., 2010). Importantly,
altered expression of miRNAs is a common trait of cancers (Far-
azi et al., 2011). Indeed, deciphering regulation of miRNA
expression may be important not only for diagnostic, but also
for therapeutic purposes (Kasinski and Slack, 2011). Due to the
way that miRNAs are generated, their expression can be regu-
lated at different levels. The first level is transcriptional as
miRNAs are synthesized from larger transcripts by RNA poly-
merase II or RNA polymerase III complexes. The next level is
posttranscriptional, as these primary miRNA precursors (pri-
miRNA) undergo at least three steps before the mature single-
stranded form. The pri-miRNA is first cleaved by Drosha to
release a hairpin-loop-shaped RNA called pre-miRNA (Lee
et al., 2003). The loop of this pre-miRNA is further cleaved by
Dicer to generate a miRNA duplex (Chendrimada et al., 2005).
The miRNA duplex is dissociated, and the passenger strand is
discarded, whereas the guide strand is loaded onto the Argo-
naute (Ago) protein to form an active RISC complex (Kawamata
and Tomari, 2010). Each of these steps is potentially subjected to
regulation because the rate of transcription of a given pri-miRNA
does not always correlate with the levels of its mature miRNA
(Thomson et al., 2006). One crucial aspect of this process is
related to the 50 terminal end of these RNA molecules. Both
RNase III enzymes, Drosha and Dicer, generate 50 ends that
contain a negatively charged monophosphate group. This 50
monophosphate is bound by specific positively charged pockets
in Dicer and Ago2, and these interactions are necessary for effi-
cient and accurate processing as well as the stability of the
mature RISC complex (Frank et al., 2010; Kawamata et al.,
2011; Park et al., 2011). Here, we unveil an unexpected posttran-
scriptional modification of the 50 monophosphate group. Spe-
cifically, we show that the previously uncharacterized human
enzyme BCDIN3D O-methylates both in vitro and in vivo the 50
terminal monophosphate group of the precursor of miR-145, re-
sulting in a complete loss of its negative charge. Consistent with
the importance of this charge for interaction with Dicer, methyl-
ated pre-miR-145 displays reduced processing by Dicer in vitro.
Accordingly, upon BCDIN3D depletion, the association of Dicer
with the product of pre-miR-145 processing increases in vivo. As
a result, depletion of BCDIN3D in human cells leads to lower
levels of pre-miR-145 and a concomitant increase of mature
miR-145. Our results also indicate that this is not limited to miR-
145 but may be responsible for the regulation of many other
miRNAs. Finally, the interest of our findings is further enhanced
by the potential involvement of BCDIN3D in cancer, as BCDIN3D
depletion in breast cancer cells abolishes their tumorigenic
phenotypes. Altogether our results uncover a human enzyme
defining a miRNA methylation pathway that antagonizes the
Dicer-dependent processing of miRNAs and that has potential
as a therapeutic target in cancer.
RESULTS
BCDIN3D Is a Methyltransferase that Targets the 50
Monophosphate of Nucleic Acids
Methylation of DNA and specific residues within histones plays
a crucial role in the epigenetic regulation of chromatin-based
processes, such as transcription and genomic organization
(Goldberg et al., 2007; Klose and Bird, 2006; Kouzarides, 2007;
Xhemalce et al., 2011). With the aim of identifying novel epige-
netic regulators, we set up a screen for previously uncharac-
terized methyltransferases that target chromatin. Among our
candidates were BCDIN3 and BCDIN3D, the human members
of the Bin3 family of putative methyltransferases. Members of
this family are found from Schizosaccharomyces pombe to
humans and share homology within their putative S-adenosyl
Methionine (SAM) binding motif (Figure 1A). The two paralogs
exist from Drosophila melanogaster to humans, whereas lower
eukaryotes possess only one Bin3 family member (Figure 1B).
We assessed the activity of purified candidate proteins by
using in vitro methyltransferase assays with purified histones
and nucleosomes as substrates and 3H-radioactive SAM as
the methyl group donor. In our assays, BCDIN3D, but not
BCDIN3, showed a specific activity in the form of a radioactive
band migrating at the level of histone H3 (around 17 kDa) in
a SDS-PAGE gel only in the presence of nucleosomes (Fig-
ure 1C). In order to test whether BCDIN3D was targeting the
tail of histone H3, we repeated the methyltransferase assay
with nucleosomes in which histone H3 carried a truncation of
its 31 N-terminal amino acids (H3DNter). As shown in Figure 1D,
the radioactive band did not disappear nor changed its migration
in the H3DNter nucleosomes, suggesting that the methylated
product was not histone H3. As the only material difference
between histones and nucleosomes was the DNA-601 used to
assemble the nucleosomes (Huynh et al., 2005), it was possible
that the methylation product was the DNA-601 itself. Staining of
the SDS-PAGE gel with ethidium bromide showed that the 601-
DNAdoesmigrate in an SDSPAGE gel forming a band around 17
KDa (Figure 1E). Moreover, BCDIN3D was able to methylate the
601-DNA in the absence of any histone (Figure 1F). However,
BCDIN3D did not target the canonical cytosines within CpG sites
because the methylation product was still observed when the
601-DNA was premethylated to saturation with the bacterial
SspI enzyme that methylates these sites (Figure 1F). Rather,
BCDIN3D targeted the 50 monophosphate generated by the
EcoRV digestion used during the 601-DNA purification proce-
dure because the methylation product was no longer observed
when the 601-DNA was pretreated with alkaline phosphatase
(Figure 1F). Importantly, the methyltransferase activity wasintrinsic to BCDIN3D as point mutations in its SAM binding
domain abolished its observed activity in our assay (Figures 1A
and 1F). While we were performing these experiments, the
homolog of BCDIN3D, BCDIN3, was reported to stabilize the
nuclear noncoding RNA 7SK by methylating its 50 g-phosphate
(Jeronimo et al., 2007; Shuman, 2007). In addition, we estab-
lished that BCDIN3D is localized in the cytoplasm (Figures
S1A–S1C available online). Finally, the activity that we observed
on the 601-DNAwasweak, i.e., themethylation reactionswere at
the limit of detection by liquid scintillation, and we needed to
expose the radioactive gels on film for 2–4 weeks in order to
detect a significant signal. Based on these observations, we
hypothesized that the bona fide target(s) of BCDIN3D may be
RNA(s) that are monophosphorylated at their 50 end(s) as shown
in Figure 1G.
BCDIN3D Affects the Levels of Precursor and Mature
Forms of miR-145
We considered that micro RNAs (miRNA) were good candidates
for being BCDIN3D targets. Indeed, although most primary
precursors of miRNAs (pri-miRNA) are transcribed by RNA
polymerase II and are 7-methyl-guanosine-capped, both the
precursor miRNAs (pre-miRNA) generated by Drosha and the
mature miRNAs generated by Dicer have 50 monophosphate
ends (Sarnow et al., 2006).
We first sought to determine a cellular system in which to iden-
tify the targets of BCDIN3D methylation. Because of global
mRNA expression data linking BCDIN3D to breast cancer (Liu
et al., 2007), we analyzed the role of BCDIN3D in a number of
cellular assays relevant to this cancer. Cells from the triple nega-
tive breast cancer cell line MDA-MB-231 have the ability to grow
in anchorage-independent conditions, a hallmark of cell trans-
formation, and to penetrate through a basement membrane
matrix, a key property of cellular invasion. Stable shRNA-medi-
ated depletion of BCDIN3D in these cells reduced their ability
to form colonies in soft agar medium (anchorage-independent
growth assay, Figure 2A). Moreover, depletion of BCDIN3D by
using this shRNA and another siRNA targeting an independent
sequence of BCDIN3D (Figure S3A) significantly decreased the
invasivenessof theMDA-MB-231cells (invasionassay, Figure2D
and Figures S2C and S2D) without greatly affecting their growth
andmigration abilities (growth assay, Figure 2B; MTT assay, Fig-
ure S2A and migration assay, Figure 2C and Figure S2B). Impor-
tantly, reintroduction of an shResistant BCDIN3D-GFP protein
into the cells expressing shBCDIN3D at levels similar to the
endogenous BCDIN3D protein (Figure 2E) fully rescued the inva-
sion defect of these cells (Figure 2F), clearly demonstrating that
the observed effects are specific.
Having confirmed the relevance of BCDIN3D in breast cancer
cells, we depleted BCDIN3D in the MCF-7 breast cancer cell line
and monitored its effect on the levels of five mature miRNAs
(miR-10b, miR-21, miR-125b, miR-145, and miR-155) that are
known to be consistently deregulated in breast cancer (Iorio
et al., 2005). As shown in Figure 3A, MCF-7 cells transfected
with an siRNA targeting the first exon of BCDIN3D (siBCDIN3D,
depletion efficiency shown in Figure S1B and Figure S3B) dis-
played significantly increased levels of mature miR-145 com-
pared to MCF-7 cells transfected with nontargeting negativeCell 151, 278–288, October 12, 2012 ª2012 Elsevier Inc. 279
Figure 1. BCDIN3D Is a Methyltransferase that Targets the 50 Monophosphate of Nucleic Acids
(A) Alignment of the SAMbinding domain of the Bin3 family members fromS. pombe, Arabidopsis thaliana, C. elegans, D.melanogaster, Musmusculus andHomo
sapiens, generated with the CLUSTAL W algorithm. The asterisks indicate the residues that, when mutated to Alanine, abolish the methyltransferase activity of
human BCDIN3D (F). The arrow indicates human BCDIN3D.
(B) Phylogenetic tree based on the alignment shown in (A), generated with the Geneious software. The dashed ellipsoid underlines the BCDIN3D cluster and the
arrow indicates human BCDIN3D.
(C) In vitro methyltransferase assay with recombinant human BCDIN3 and BCDIN3D, 3H-radioactive SAM as methyl group donor, and either histones or
nucleosomes as substrate. The reactions were loaded on a 15% SDS-PAGE gel, fixed, and subjected to autoradiography. The radioactive band observed in the
BCDIN3D/nucleosome lane comigrates with histone H3.
(D) In vitro methyltransferase assay with recombinant BCDIN3D, 3H-SAM, and nucleosomes, in which histone H3 is either full length (H3) or is truncated of the 31
first amino-acids (H3DNter). The truncation makes H3DNter migrate faster (Coomassie staining, right), but does not modify the migration of the radioactive band
(autoradiography, left).
(E) Onemicrogramof histones and nucleosomeswere loaded on a 15%SDS-PAGEgel and stainedwith ethidium bromide. The band observed in the nucleosome
lane corresponds to the 601-DNA used to assemble the nucleosomes.
(F) In vitro methyltransferase assay using recombinant human BCDIN3D-WT and BCDIN3D-D72G74A catalytic mutant, 3H-radioactive SAM as methyl group
donor and purified 601-DNA as substrate. The 601-DNA is generated by cleavage from a plasmid harboring multiple tandem repeats of the sequence flanked by
EcoRV restriction sites. Prior to the methyltransferase assay with BCDIN3D, the 601-DNA was either CpG methylated by using the Ssp1 bacterial methyl-
transferase and/or treated with alkaline phosphatase (AP) that removes the 50-alpha-phosphate left from the EcoRV digestion. The DNA from the methyl-
transferase assays with BCDIN3Dwas purified, loaded on a native 6% PAGE gel, stained with ethidium bromide (lower), fixed, and subjected to autoradiography
(upper).
(G) Schematic representing the inferred methyltransferase activity of BCDIN3D on a 50 monophosphorylated ribonucleotide. The dashed ellipsoid underlines the
50-alpha-phosphate group.
See also Figure S1.
280 Cell 151, 278–288, October 12, 2012 ª2012 Elsevier Inc.
Figure 2. BCDIN3D Depletion Suppresses Tumorigenic Phenotypes In Vitro
(A) Stable depletion of BCDIN3D in the MDA-MB-231 breast cancer cells abolishes anchorage-independent growth. Microscopic image of MDA-MB-231
[shBCDIN3D] and MDA-MB-231 [shNC] cells growing in soft agar after 4 weeks incubation (see Extended Experimental Procedures for further detail).
(B–D) Stable BCDIN3D depletion substantially impairs invasiveness, but not growth andmigration, of MDA-MB-231 cells. MDA-MB-231 [shBCDIN3D] andMDA-
MB-231 [shNC] cells were analyzed with the xCELLigence system, which allows to assess cellular growth (B, growth assay), migration through a 8 mM pore size
membrane (C, migration assay) or invasion through a 8 mMpore size membrane coated with Matrigel (D, invasion assay) in parallel and in real time. The cells were
trypsinized and loaded in quadruplets onto an E-plate (B, growth assay), CIM-plate (C, migration assay) or CIM-plate coated with 1/40 dilution of Matrigel (D,
invasion assay). The cell index was measured every 15 min for 48 hr. The results of the assay are represented as normalized cell index. Error bars represent SEM
values.
(E) MDA-MB-231 [shBCDIN3D+BCDIN3DshR(esistant)-GFP] express BCDIN3DshR-GFP at levels similar to endogenous BCDIN3D protein. MDA-MB-231
[shBCDIN3D+BCDIN3DshR-GFP], MDA-MB-231 [shBCDIN3D+GFP], and MDA-MB-231 [shNC+GFP] cell lines were generated as indicated in the Extended
Experimental Procedures. Whole-cell extracts were analyzed by western blot with anti-BCDIN3D antibody and the loading control alpha-tubulin. The two panels
showing the endogenous and BCDIN3DshR-GFP are from the same exposure of the same blot.
(F) Expression of BCDIN3DshR-GFP in MDA-MB-231 [shBCDIN3D] cell lines suppresses their invasion defect. The MDA-MB-231 [shBCDIN3D+BCDIN3DshR-
GFP], MDA-MB-231 [shBCDIN3D+GFP]. and MDA-MB-231 [shNC+GFP] cell lines were analyzed as in (B–D) and the invasion assays are shown. Error bars
represent SEM values.
See also Figure S2.control siRNAs (siNC). A similar increase in mature miR-145
levels was observed when MCF-7 cells were transfected with
an independent pool of siRNAs targeting the second exon of
BCDIN3D (Figures S3A–S3C). Moreover, a milder but reproduc-
ible increase of mature miR-145 levels was observed in MDA-
MB-231 cells transfected with siBCDIN3D compared to cells
transfected with siNC (Figure S3D) or the MDA-MB-231 cellsstably expressing shBCDIN3D compared to those expressing
shNC or shBCDIN3D rescued with the BCDIN3DshR-GFP
construct (Figure S3E). Importantly, the results obtained by
quantitative reverse transcription and PCR (qRT-PCR) were
confirmed by northern blot with a probe against miR-145 in the
nontransformed but immortalized BJ+TERT cells that express
higher levels of miR-145 than MCF-7 cells (Figures S3F andCell 151, 278–288, October 12, 2012 ª2012 Elsevier Inc. 281
Figure 3. siRNA-Mediated Depletion of BCDIN3D Changes the Levels of Precursor and Mature Forms of miR-145
MCF-7 cells were transfected with a siRNA targeted against the first exon of BCDIN3D (siBCDIN3D) or with non targeting siRNAs as a negative control (siNC).
(A) The levels of the indicated miRNAs were analyzed by quantitative reverse transcription and PCR (qRT-PCR) analysis. The data are normalized to the U6 RNA
and to siNC cells. Error bars represent SEM values.
(B) Transcript levels of the pri-miR-145 were not significantly altered upon BCDIN3D depletion. The pri-miRNA levels were analyzed by qRT-PCR and normalized
to the ALAS1 and B2M mRNAs and to siNC cells. Error bars represent SEM values.
(C) The levels of pre-miR-145 are reduced upon BCDIN3D depletion. The pre-miRNA levels were analyzed by qRT-PCR and normalized to the 5S and U6 RNAs
and to siNC cells. Error bars represent SEM values.
(D) Schematic view of the IRS-1 mRNA and the sequences targeted by miR-145.
(E) In a similar manner tomiR-145 overexpression, BCDIN3D depletion affects IRS-1 expression at the protein level. These effects are not due to p53 stabilization.
MCF-7 cells were cotransfectedwithmiR-145mimic, siBCDIN3D, and siNC as indicated and analyzed bywestern blot with antibodies against IRS-1, p53 and the
loading control GAPDH.
(F) BCDIN3D depletion significantly reduces the expression of the luciferase reporter gene fused to the 30UTR of the IRS-1 mRNA. siBCDIN3D and siNC
transfected MCF-7 cells were transfected with pMirTarget (Origene) containing or not the 30-UTR of IRS1 fused to the luciferase reporter gene and after 24 hr, the
cells were lysed and the luciferase activity wasmeasured in a luminometer. Shown are results from a typical experiment in quadruplets. Error bars represent SEM
values. The transfection efficiency of the plasmids, as assessed by the expression of RFP gene contained in the pMirTarget plasmid, was identical in all samples.
(G) miR-145 inhibition rescues the invasion defect ofMDA-MB-231 cells transfectedwith siBCDIN3D.MDA-MB-231were transfected according to the procedure
schematized on the left with siRNAs against BCDIN3D and negative control, followed by anti miR-145 inhibitors and negative control. Twenty-four hours after the
transfection of themiRNA inhibitors, the cells were trypsinized and analyzed as in Figures 2B–2D; the invasion assays are shown. Error bars represent SEMvalues.
See also Figure S3.
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Figure 4. BCDIN3D Dimethylates the 50
Phosphate Group of (Pre-)miR-145 In Vitro
(A) BCDIN3D preferentially methylates pre-miR-
145. In vitro methyltransferase assay using re-
combinant GST-BCDIN3D (1–8) or GST (9–10),
3H-radioactive SAM as methyl group donor and
the following synthetic DNA and RNA molecules
as substrate (1) deoxy-pre-miR-145 [50-OH]; (2)
deoxy-pre-miR-145 [50-P]; (3&9) pre-miR-145
[50-OH]; (4 and10) pre-miR-145 [50-P]; (5) duplex
miR-145 [50-P]; (6) miR-145 [50P]; (7) miR-145*
[50P]; and (8) mock. The nucleic acids were purified
and analyzed by autoradiography (left) and liquid
scintillation (right). Error bars represent SD values.
Full recovery of nucleic acids after purification was
verified with a spectrophotometer.
(B–D) The product of BCDIN3D methylation is a 50
phospho-dimethyl. (B) In vitro methyltransferase
assay as in (A) using as substrate synthetic pre-
miR-145 molecules that have [50-OH], [50-P], [50-
Pme1] or [50-Pme2] ends (see Figure 1G). Lower
panel shows the Staining with ethidium bromide of
the gel used for the autoradiography shown in the
upper panel. (C) Synthetic pre-miR-145 molecules
that have [50-OH], [50-P], [50-Pme1] or [50-Pme2]
ends were ligated with the T4 RNA Ligase 1. The
circular RNA molecules migrate faster than the
linear molecules. pre-miR [50-Pme2] is resistant to
ligation. (D) Synthetic pre-miR-145 [50-P] was
in vitro methylated as in (A) prior to ligation with T4
RNA Ligase 1. Left panel shows the ethidium
bromide staining of the gel used for the autoradi-
ography shown in the right panel. The pre-miR-
145 molecules that were methylated by BCDIN3D
were also resistant to ligation.S3G). Interestingly, the levels of pri-miR-145 were not increased
upon BCDIN3D depletion (Figure 3B), whereas the levels of
pre-miR-145 were significantly decreased (Figure 3C). This sug-
gested that the upregulation of miR-145 was not due to a tran-
scriptional effect but rather to a downstream effect on either
the processing of miR-145 and/or its stability.
The increase in the levels of mature miR-145 seen after
BCDIN3D depletion resulted in several expected functional
consequences. Indeed, similar to miR-145 overexpression,
BCDIN3D depletion decreased the levels of IRS1, a previously
established miR-145 target (Shi et al., 2007; Spizzo et al., 2010),
at both the protein and RNA levels (Figures 3D and 3E and data
not shown) and significantly reduced the expression of the lucif-
erase reporter gene fused to the 30UTR of the IRS1 mRNA (Fig-
ure 3F). Moreover, the miR-145 motif was significantly enriched
(p=0.0026) in the 30UTRof genesdownregulated uponBCDIN3D
depletion, whereas the other four miRNAs tested were not (see
below). Finally, despite the apparently mild increase of miR-145
levels in MDA-MB-231 cells transfected with siBCDIN3D com-
pared to siNC (Figure S3D), the transfection ofmiR-145 inhibitors
totally or partially rescued the invasion defect of these cells, de-
pending on the density of the matrigel (Figure 3G and data not
shown). Altogether, these results strongly suggest that BCDIN3D
regulates mature miR-145 levels and that miR-145 is a functional
mediator of the phenotypic effects of BCDIN3D depletion.BCDIN3D Dimethylates the 50 Phosphate Group of
(Pre-)miR-145 In Vitro
To test whether miR-145 is a direct target of BCDIN3D activity,
we performed in vitro methyltransferase assays by using re-
combinant BCDIN3D and synthetic forms of miR-145 and
3H-SAM, and analyzed them by autoradiography and liquid scin-
tillation counting. In these assays, BCDIN3D showed a strong
activity and a preference for the precursor form of miR-145
(pre-miR-145) compared to either the double-stranded miR-
145 or the single-stranded miR-145 and its passenger miR-
145* (Figure 4A). Importantly, BCDIN3D did not methylate the
50OH unphosphorylated form of neither pre-miR-145, miR-145,
or miR-145* (Figure 4A and data not shown), validating the spec-
ificity of BCDIN3D activity toward the 50 monophosphate. Finally,
BCDIN3D could not methylate the 50P deoxy-ribonucleotide
formof pre-miR-145 confirming that BCDIN3Dhas indeed a pref-
erence for RNA molecules (Figure 4A).
As illustrated in Figure 1G, the 50 monophosphate group
contains two negatively charged oxygen moieties [-O] that
can be subject to methylation [-O-CH3]. We therefore sought to
determine whether BCDIN3D methylates one or both available
oxygen moieties. To this purpose, we synthesized pre-miR-145
molecules in which the 50 monophosphate group was either
mono- (50Pme1) or dimethylated (50Pme2). We first submitted
them to in vitro methyltransferase assays with recombinantCell 151, 278–288, October 12, 2012 ª2012 Elsevier Inc. 283
Figure 5. Pre-miR-145 Is Also Modified in
a BCDIN3D-Dependent Manner In Vivo
(A) Synthetic pre-miR-145molecules that have [50-
OH], [50-P], [50-Pme1], or [50-Pme2] 50 ends were
treated with Terminator 50-P-dependent exonu-
clease that is a processive 50-30 exonuclease that
digests RNAs having a 50 monophosphate. Pre-
miR [50-Pme2] is resistant to this treatment.
(B) RNA from MCF-7 cells treated or not with
Terminator was migrated on an Agilent Total
Eukaryotic RNA pico Chip. The treatment was
specific as the Terminator fully digested the 18S
and 28S rRNA, which have 50 monophosphates
but did not digest the 5S RNA, which has a 50
triphosphate.
(C) RNA treated as in (B) was analyzed by reverse
transcription and PCR with primers specific for
pre-miR-21, pre-miR-145, miR-21, miR-145, and
5S. The 5SRNA is known to be 50 triphosphate and
is used to control for equal RNA recovery. The
indicated RNAs were analyzed by quantitative RT-
PCR and normalized to the 5S RNA and to the
[-Terminator] sample (graph on right). Error bars
represent SEM values. To facilitate the visualization of the assay, the PCRs were also analyzed by semiquantitative PCR (left). For each primer, the semi-
quantitative PCRswere performed in parallel with the quantitative PCRs andwere stopped at the same cycle as the quantitative PCR reached the threshold of the
less abundant sample. The treatment with Terminator fully digests miR-145 but not pre-miR-145. The asterisk indicates a nonspecific band.
See also Figures S4, S5, and S6.BCDIN3D and 3H-radioactive SAM. BCDIN3D could still meth-
ylate pre-miR-145 [Pme1] but not pre-miR-145 [Pme2] (Fig-
ure 4B), strongly suggesting that BCDIN3D can methylate both
oxygen moieties of the 50 monophosphate end. In order to
determine the ratio of mono- and dimethylated 50 monophos-
phate products in our in vitro methyltransferase assays, we ex-
ploited the enzymatic properties of T4 RNA Ligase 1. This
enzyme catalyzes the ligation of a 50 monophosphate nucleic
acid donor to a 30 hydroxyl-terminated nucleic acid acceptor
through the formation of a 30/50 phosphodiester bond. As ex-
pected, the ligation reaction circularized the synthetic pre-miR-
145 50 monophosphate RNA molecule resulting in a faster
migrating band (Figure 4C). In our conditions, T4 RNA Ligase
1 could still efficiently ligate pre-miR-145 [Pme1] but not pre-
miR-145 [Pme2], thus providing us with a tool to discriminate
between the mono- and the dimethylated forms of the 50 mono-
phosphate end (Figure 4C). As shown in Figure 4D, pre-miR-
145 methylated with BCDIN3D (radioactive band on the right)
was fully resistant to ligation with T4 RNA Ligase 1, indicating
that the product of BCDIN3D methylation is a 50Pme2.
Pre-miR-145 Is Modified by BCDIN3D In Vivo
To determine whether BCDIN3D also targets miR-145 and/or
its precursor in vivo, we set up an assay that takes advantage
of the fact that the 50Pme2 end is also resistant to treat-
ment with the Terminator 50 Phosphate-Dependent Exonu-
clease that specifically digests RNAs having a 50 monophos-
phate (Figure 5A). We treated RNA purified from MCF-7 cells
transfected with siBCDIN3D and siNC with the Terminator
enzyme and analyzed the resulting RNAs by quantitative reverse
transcription and PCRwith specific primers for pre-miR-145 and
miR-145 as well as controls (Figures 5B and 5C). To verify that
the treatment with Terminator was effective, the RNAs, treated284 Cell 151, 278–288, October 12, 2012 ª2012 Elsevier Inc.with either Terminator or mock, were analyzed by electropho-
resis on an Agilent Total RNA Pico chip. As shown on Fig-
ure 5B, Terminator fully digested the 28S and 18S rRNAs,
which have 50 monophosphate ends but left intact the 5S
rRNA, which has a 50 triphosphate end. The treatment also fully
digested miR-21, which is known to be monophosphate (Affy-
metrix ENCODE Transcriptome Project, 2009) (Figure 5C).
Under these conditions, a significant proportion of pre-miR-
145, but not miR-145, was resistant to digestion with Terminator
in siNC transfected MCF-7 cells (Figure 5C). Moreover, the
Terminator resistant fraction of pre-miR-145 was significantly
reduced in siBCDIN3D-treated MCF-7 cells (Figure 5C). This
shows that the 50end of pre-miR-145 is modified in a BCDIN3D-
dependent manner in vivo. Together with the in vitro activity of
BCDIN3D on pre-miR-145, this suggests that pre-miR-145 is
dimethylated at its terminal 50 monophosphate. Interestingly,
a smaller portion of pre-miR-21 was also resistant to Terminator
suggesting that miR-21 is also a BCDIN3D target. This could
explain the mild increase of the mature levels of miR-21 in
some of our assays.
Our global whole RNA analysis in siBCDIN3D and siNC-
treated MCF-7 cells also suggested that miR-145 is not the
only target of BCDIN3D. Indeed, mRNAs downregulated in
siBCDIN3D cells were very significantly enriched with multiple
putative miRNA targeting sequences (Figure S4 and Extended
Experimental Procedures). Moreover, we found additional miR-
NAs whose expression is increased in siBCDIN3D compared
to siNC cells through miRNA profiling with the miRCURY LNA
PCR platform from Exiqon (Figure S5 and Extended Experi-
mental Procedures). In particular, we determined that the pre-
cursor of miR-23b was also modified in a BCDIN3D-dependent
manner in vivo (Figure S5D) and in vitro (Figure S6), indicating
that BCDIN3D robustly modifies other miRNA targets.
Figure 6. BCDIN3D Interacts with Dicer and Its Depletion Affects miR-145 Association with Dicer
(A) BCDIN3D specifically interacts with Dicer. Flag eluates from isogenic HELA-S3-Flp-In (-) and HELA-S3-Flp-In-BCDIN3D-Flag (BCDIN3D-Flag) stable cell lines
coimmunoprecipitated with an anti-Flag antibody were analyzed by western blotting with the indicated antibodies (see Extended Experimental Procedures for
further detail).
(B) The interaction between BCDIN3D and Dicer is sensitive to treatment with RNase A. Flag co-IPs were performed as in (A) in the presence of mock or 1 or 5 ml of
RNase A (see Extended Experimental Procedures for further detail). The co-IPs were analyzed by Coomassie staining to confirm equal recovery of BCDIN3D
(lower) and by western blot with the Dicer antibody (upper).
(C) Upon BCDIN3D depletion, the association of Dicer with miR-145, the product of pre-miR-145 processing, is significantly increased. MCF-7 cells transfected
with siBCDIN3D or siNC were subjected to RNA-immunoprecipitation with the indicated antibodies (see Extended Experimental Procedures for further detail).
RNA from the immunoprecipitates was purified and the levels of miR-21 and miR-145 were analyzed by qRT-PCR. The data are normalized to the 5S and U6
RNAs and to siNC cells. Error bars represent SEM values.
(D and E) Synthetic pre-miR-145molecules that have [50-OH], [50-P], [50-Pme1], or [50-Pme2] 50 ends were incubated with human Dicer or mock at 1 mM of MgCl2
for 30, 60 or 120 min as indicated (see Extended Experimental Procedures for further detail). The Dicer processing reactions were loaded on a 15% Urea-PAGE
gel and stained with ethidium bromide. The gel was photographed with the Chemidoc XRS+ system from Biorad (D, lower) and analyzed by northern blot with an
anti-miR-145 probe (D, upper). The miR-145 product was quantified by using the Image Lab Software (E).
See also Figure S7.BCDIN3D Affects miR-145 Association with Dicer
These results prompted us to determine at what step in the
RNAi pathway BCDIN3D participates. To this end, we first
probed for in vivo interactions between BCDIN3D and pro-
teins involved in the RNAi pathway. We performed anti-Flag
coimmunoprecipitations (co-IP) from HeLa-S3-Flp-In control
and -BCDIN3D-Flag stable cell lines followed by elution with
a Flag peptide. This procedure highly reduced nonspecific
interactions as shown by the lack of Tubulin alpha in our co-
IPs, a common contaminant of Flag-affinity purifications (Greg-
ory et al., 2004) (Figure 6A). We reproducibly detected an
interaction of BCDIN3D with Dicer but not with other proteins
of the RNAi pathway (Figure 6A). Importantly, we could not
detect an interaction between BCDIN3D and TRBP, which
stably interacts with Dicer and participates in the processing
of pre-miRNAs to mature miRNAs (Chendrimada et al., 2005)
(Figure 6A). Interestingly, the observed interaction between
BCDIN3D and Dicer is disrupted by treatment with RNase A (Fig-
ure 6B), suggesting that the interactionmay bemediated through
RNA(s). The binding of BCDIN3D to Dicer is an additional strongindicator that BCDIN3D has a direct role in the processing of
miRNAs.
The observed increase in the levels ofmiR-145 uponBCDIN3D
depletion could be due to either increased processing of miR-
145, to increased stability of the mature miR-145, or to both. In
order to distinguish among these three possibilities, we deter-
mined how depletion of BCDIN3D affected the association of
miR-145 with proteins involved with its processing from pri-
to pre- to mature miRNA. We performed RNA immunopre-
cipitations (RIP) with specific antibodies against Drosha, Dicer,
and Ago2 in MCF-7 cells treated with either siBCDIN3D or
siNC. As shown in Figure 6C, depletion of BCDIN3D significantly
and specifically increased the association of miR-145 with
Dicer. This suggests that depletion of BCDIN3D augments the
processing of pre-miR-145 by Dicer into miR-145. Surprisingly,
BCDIN3D depletion did not increase miR-145 association with
Ago2, although it mildly increased the association of Ago2 with
miR-21, another lesser BCDIN3D target. This may be a direct
consequence of the fact that miR-145 has a guanine at position
1. The structure of the MID domain of human Ago2 was recentlyCell 151, 278–288, October 12, 2012 ª2012 Elsevier Inc. 285
Figure 7. Model for the Mode of Action of BCDIN3Dsolved and indicated that a loop within this domain discriminates
against cytosines and guanines thereby lowering hAgo2 affinity
for miRNAs that start with these residues (Frank et al., 2010).
Another alternative albeit not exclusive explanation is that
although the association of miR-145 with hAgo2 remains appar-
ently unchanged, the increased association rate is actually
compensated by a similarly increased dissociation rate.
The 50 Phospho-Dimethyl Modification Reduces the
Processing of Pre-miR-145 by Dicer
All of our results point to the fact that downregulation of
BCDIN3D augments the Dicer-dependent processing of pre-
miR-145 into miR-145. First, depletion of BCDIN3D leads to
a reduction of pre-miR-145 levels and a concomitant increase
of mature miR-145 levels (Figures 3A–3C). Second, upon
BCDIN3D depletion, the association of Dicer with the product
of pre-miR-145 processing increases (Figure 6C). Finally, we
find that BCDIN3D modifies the pre- but not the mature miR-
145 in vivo (Figure 5C), even though they have the same 50end.
Indeed, because the mature miR-145 is positioned on the 5p
arm of the pre-miR-145 hairpin, the 50end of the mature miR-
145 is not produced by Dicer and is therefore the same as
the 50end of pre-miR-145. Together with the RIP results, this
strongly suggests that the 50 methylated pre-miR-145 molecules
are not efficiently processed by Dicer in vivo. To test whether this
effect is directly mediated by Dicer, we performed in vitro Dicer
processing assays where human recombinant Dicer was incu-
bated with synthetic pre-miR-145 molecules that have [50-OH],
[50-P], [50-Pme1] or [50-Pme2] ends at physiological Mg2+ ions
concentration (0.5–1 mM) (Gu¨nther, 2006). Under these condi-
tions, the processing of pre-miR-145 [50-Pme2] by Dicer was
impaired compared to the other pre-miR-145 molecules (Fig-
ure 6D and Figure S7). The decrease in processing efficiency
may result from the loss of the negative charge following meth-
ylation (Figure 1G) that in turn may affect the recognition of the
50 monophosphate of the pre-miRNA by Dicer (Figure 7). This
is supported by recent findings that humanDicer contains abasic
motif that anchors the 50 monophosphate terminus (Park et al.,
2011).
DISCUSSION
Here we uncover an enzymatic activity mediated by human
BCDIN3D, which methylates both oxygen moieties of a phos-286 Cell 151, 278–288, October 12, 2012 ª2012 Elsevier Inc.phate group on nucleic acids. Specifically, we show that
BCDIN3D modifies the 50 monophosphate end of miRNAs in-
cluding pre-miR-145 and pre-miR-23b. Methylation of the 50
monophosphate of pre-miRNAs by BCDIN3D inhibits their pro-
cessing by Dicer. This inhibition is consistent with the recent
finding that human Dicer possesses a basic motif that accom-
modates the negatively charged 50 monophosphate of pre-
miRNAs (Park et al., 2011). Importantly, the interaction between
Dicer and the 50 monophosphate is necessary for efficient and
accurate processing of pre-miRNAs. (Park et al., 2011). Methyl-
ation of both oxygen moieties by BCDIN3D neutralizes the nega-
tive charges of the 50 monophosphate group, This abrogation of
charge may prevent the association of pre-miRNAs with the
Dicer basic motif and result in the inhibition of Dicer activity.
Together these findings suggest a model whereby direct methyl-
ation of pre-miRNAs by BCDIN3D generates a pool of pre-
miRNAs that is less responsive to processing by Dicer (Figure 7).
The fact that BCDIN3D can associate with Dicer (but not TRBP)
may be an indication that BCDIN3D acts on miRNAs while com-
plexedwith Dicer. However, it is also possible that the interaction
between Dicer and BCDIN3D functions in other aspects of this
pathway.
BCDIN3D prefers RNA to DNA because the deoxy- form of
pre-miR-145 is a far inferior substrate compared to its ribonucle-
otide counterpart (Figure 4A). Given that the 50 monophosphate
group is identical between these molecules, other features, such
as tri-dimensional structure or the presence of uracil instead of
thymine, could determine this specificity. Of course, the possi-
bility remains that BCDIN3D could also target DNA, which may
be revealed under specific conditions or biological processes.
This notion is supported by an example from Caenorhabditis
eleganswhereDicer is converted froma ribonuclease to a deoxy-
ribonuclease through the action of a caspase during apoptosis
(Nakagawa et al., 2010).
miRNAs are involved in numerous cellular effects and often
several miRNAs function in concert to regulate a given bio-
logical function. Because BCDIN3D regulates a subset of
miRNAs, this enzyme may function in specific biological pro-
cesses depending on the cellular and/or physiological context.
One possible role of BCDIN3D in cancer cells may be to pro-
mote cellular invasion (Figure 2). This idea is consistent with
the finding that BCDIN3D mRNA is overexpressed in highly
tumorigenic breast cancer stem cells and BCDIN3D is included
in an ‘‘invasiveness’’ gene signature (Liu et al., 2007). In addi-
tion, two established in vivo targets of BCDIN3D, pre-miR-
145 and pre-miR23b, are able to suppress the process of
cellular invasion (Sachdeva et al., 2009; Shi et al., 2007; Spizzo
et al., 2010; Zhang et al., 2011). Collectively, these findings
strongly suggest that the negative effect of BCDIN3D depletion
on invasion could be due to its effects on several miRNAs.
Indeed, a recent genome-wide functional screen showed that
69 out of 900 miRNAs tested were able to inhibit cellular
invasion (Zhang et al., 2011). The potential of BCDIN3D to
affect many miRNAs simultaneously may allow it to tightly con-
trol specific pathways, including cellular invasion. Future work
should allow us to establish whether this effect may be ex-
plored for therapeutic targeting in breast and possibly other
cancers.
EXPERIMENTAL PROCEDURES
The details of all siRNAs, synthetic RNAs, primers and antibodies used in the
study are provided in Tables S1, S2 and S3. Extended Experimental Proce-
dures are included in the Supplemental Information and/or are available
upon request.
Knockdown Experiments
ON-TARGETplus siRNAs against BCDIN3D and control were purchased from
Dharmacon and reverse-transfected in two rounds into MCF7, MDA-MB-231
or BJ+TERT cells by using Lipofectamine RNAiMAX from Invitrogen or
HiPerfect from QIAGEN. miR-145 mimics and inhibitors were from Ambion.
The MDA-MB-231 clones stably expressing shRNAs against BCDIN3D or
control were generated by transfecting MDA-MB-231 cells with the pRS
vectors containing 29-mer shRNA against BCDIN3D (TR317908, t1368843)
and noneffective scrambled shRNAs (TR30012) from Origene respectively.
The shBCDIN3D rescue clones were generated by transfecting tGFP-tagged
BCDIN3D carrying a silent C324/C327A mutation.
Cellular Assays
For the soft agar colony assays, 3 3 104 cells were plated in 0.35% agar in
complete growth medium in 6-well plates and colonies were analyzed after
4 to 5 weeks. The real-time growth, migration, and invasion assays were per-
formed with the xCELLigence system from Roche following the manufac-
turer’s instructions. A 1/40th dilution of Matrigel was used to coat the upper
chamber of the CIM plate for the invasion assays.
RNA Analysis
Total RNA and proteins were extracted from the same cells by using the RNA/
Protein purification kit from Norgen. 20–200 ng of total RNA was used for
detection of miRNAs with the mirVana qRT-PCR miRNA detection kit and/or
the Taqman MicroRNA Reverse Transcription Kit from Applied Biosystems.
Real-time PCR analysis was performed on a StepOne Plus system or Vii7A
from Applied Biosystems. The northern blots were performed as previously
described (Xhemalce and Kouzarides, 2010).
Modified RNAs
Precursor, mature, and passenger miR-145 carrying 50OH, 50P, 50Pme1, or
50Pme2 modifications were custom synthesized by IBA GmbH.
In Vitro RNA Methyltransferase Assays
These assays were performed in a total volume of 100 ml in 25 mM Tris-HCl
[pH 8], 150 mM NaCl, 2 mM KCl, 10% glycerol, 1 mM EDTA, 1 mM DTT sup-
plemented with EDTA-free Complete Protease Inhibitor cocktail from Roche,
and 80 U of RNaseOUT from Invitrogen with 1 mg of recombinant BCDIN3D,
4 ml of 20 mMsynthetic RNAs, and 4 ml of 3H-SAM (PerkinElmer NET155250UC)
for 2 hr at 37C.
In Vitro Dicer Processing Assays
These assays were performed essentially as described (Park et al., 2011) with
100 pmol of synthetic pre-miRNA, 500 ng of recombinant humanDicer in a total
volume of 15 ml in 100 mM KCl, 10 mM Tris-HCl [pH 8], 0.1 mM EDTA, 0.5 or
1 mM MgCl2, 0.5 mM dTT supplemented with 0.5 U/ml RNaseOUT for the
indicated times at 37C.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and three tables and can be found with this article online at http://dx.
doi.org/10.1016/j.cell.2012.08.041.
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